(Q37852615)

24 August 2017

1 reference

title

Phenotype-genotype correlation in familial breast cancer (English)

1 reference

24 August 2017

1 reference

2

Jorge S Reis-Filho

1 reference

24 August 2017

3

Sunil R Lakhani

1 reference

24 August 2017

Ana Cristina Vargas

1

1 reference

24 August 2017

publication date

12 March 2011

1 reference

Journal of Mammary Gland Biology and Neoplasia

24 August 2017

published in

1 reference

24 August 2017

volume

16

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

27-40

1 reference

https://scigraph.springernature.com/pub.10.1007/s10911-011-9204-6

24 August 2017

exact match

0 references

cites work

The changing global patterns of female breast cancer incidence and mortality

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Cancer susceptibility and the functions of BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

The pathology of inherited breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Low expression of bcl-2 in Brca1-associated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Histopathological criteria and selection algorithms for BRCA1 genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Correlation between p53 immunostaining patterns and gene sequence mutations in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Targeted therapy for cancer using PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Hereditary breast cancer: from molecular pathology to tailored therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Expression of BRCA1 protein in breast cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Pathology of hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Ductal carcinoma in situ in BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Molecular and in silico analysis of BRCA1 and BRCA2 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A crucial role for fibroblast growth factor signaling in embryonic mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

An update of HNPCC (Lynch syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Clues to the pathogenesis of familial colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Association of rare MSH6 variants with familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Immunohistochemical characteristics of colorectal carcinoma with DNA replication errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Microsatellite instability in hereditary and sporadic breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Mismatch repair genes hMLH1 and hMSH2 may not play an essential role in breast carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

E-cadherin-catenin cell-cell adhesion complex and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Germline E-cadherin mutations in familial lobular breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Morphological types of breast cancer in family members and multiple primary tumours: is morphology genetically determined?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Germline mutational analysis of CDH1 and pathologic features in familial cancer syndrome with diffuse gastric cancer/breast cancer proband in a Chinese family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

PTEN: one gene, many syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

PTEN deficiency: a role in mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Screening-detected breast carcinoma in a patient with Cowden syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

21 January 2018

Cowden disease: a review

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Male breast cancer in Cowden syndrome patients with germline PTEN mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Germline TP53 mutations and Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

BeyondBRCA1andBRCA2wild-type breast and/or ovarian cancer families: germline mutations inTP53andPTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Susceptibility pathways in Fanconi's anemia and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Fanconi anemia and its diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

The emerging landscape of breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Analysis of PALB2/FANCN-associated breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

PALB2/FANCN: recombining cancer and Fanconi anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Mechanism of eukaryotic homologous recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Mutation of the RAD51C gene in a Fanconi anemia-like disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Association of BRCA1 with Rad51 in mitotic and meiotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Characterization of tumor-associated Chk2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Fanconi anemia and breast cancer susceptibility meet again

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-011-9204-6

Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations

21 January 2018

1 reference

12 December 2020

Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

1 reference

12 December 2020

Intraductal component and BRCA1-associated breast cancer

1 reference

12 December 2020

Comparison between genotype and phenotype identifies a high-risk population carrying BRCA1 mutations

1 reference

12 December 2020

Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges

1 reference

12 December 2020

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

12 December 2020

Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences

1 reference

12 December 2020

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

1 reference

12 December 2020

Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers.

1 reference

12 December 2020

A new variant database for mismatch repair genes associated with Lynch syndrome

1 reference

12 December 2020

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

1 reference

12 December 2020

Breast cancer in an MSH2 gene mutation carrier

1 reference

12 December 2020

Histopathological features of breast cancer in carriers of ATM gene variants

1 reference

12 December 2020

Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ

1 reference

12 December 2020

Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast

1 reference

12 December 2020

Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability

1 reference

12 December 2020

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

12 December 2020

Update on familial cancer syndromes and the skin

1 reference

12 December 2020

2009 Version of the Chompret Criteria for Li Fraumeni Syndrome

1 reference

12 December 2020

Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling

1 reference

12 December 2020

Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families

1 reference

12 December 2020

The genetic attributable risk of breast and ovarian cancer

1 reference

12 December 2020

Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas

1 reference

12 December 2020

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

1 reference

12 December 2020

Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression.

1 reference

12 December 2020

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

1 reference

12 December 2020

Expression of hMSH2 and hMLH1 in colorectal carcinomas with microsatellite instability

1 reference

12 December 2020

Cowden disease and Lhermitte Duclos disease, markers of breast carcinoma: report of two patients

1 reference

12 December 2020

Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells

1 reference

12 December 2020

Breast cancer immunohistochemistry can be useful in triage of some HNPCC families

1 reference

12 December 2020

Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer

1 reference

12 December 2020

Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus

1 reference

12 December 2020

Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53

1 reference

12 December 2020

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

12 December 2020

Absence of microsatellite instability in mucinous carcinomas of the breast.

1 reference

12 December 2020

Role for ATM in DNA damage-induced phosphorylation of BRCA1

1 reference

12 December 2020

Breast Cancer Survival and Tumor Characteristics in Premenopausal Women Carrying theCHEK2*1100delCGermline Mutation

1 reference

12 December 2020

Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014-1019, 2002

1 reference

12 December 2020

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

1 reference

12 December 2020

Classification of missense variants of unknown significance inBRCA1based on clinical and tumor information

1 reference

12 December 2020

Novel indications for BRCA1 screening using individual clinical and morphological features

1 reference

12 December 2020

Microsatellite instability in medullary breast carcinomas

1 reference

12 December 2020

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

1 reference

12 December 2020

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors

1 reference

12 December 2020

Immunophenotypic predictive profiling of BRCA1-associated breast cancer

1 reference

12 December 2020

CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry

1 reference

12 December 2020

The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2

1 reference

12 December 2020

Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma

1 reference

12 December 2020

A cancer family syndrome in twenty-four kindreds

1 reference

12 December 2020

High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome

1 reference

12 December 2020

Cowden's disease: clinical and molecular genetic findings in a patient with a novel PTEN germline mutation

1 reference

12 December 2020

10.1007/S10911-011-9204-6

Identifiers

DOI

1 reference

24 August 2017

1 reference